These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37248914)

  • 21. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
    Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
    Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Garcia-Diaz AI; Vendrell P; Bargallo N; Tolosa E; Junque C
    Mov Disord; 2014 Oct; 29(12):1495-503. PubMed ID: 25100674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.
    Danti S; Toschi N; Diciotti S; Tessa C; Poletti M; Del Dotto P; Lucetti C
    Eur J Neurol; 2015 Dec; 22(12):1564-72. PubMed ID: 26212370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
    Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.
    Pieperhoff P; Südmeyer M; Dinkelbach L; Hartmann CJ; Ferrea S; Moldovan AS; Minnerop M; Diaz-Pier S; Schnitzler A; Amunts K
    Cortex; 2022 Jun; 151():188-210. PubMed ID: 35439717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature.
    Sarasso E; Agosta F; Piramide N; Filippi M
    J Neurol; 2021 Sep; 268(9):3144-3179. PubMed ID: 32378035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroanatomical changes in early Parkinson's disease with mild cognitive impairment: a VBM study; the Parkinson's Disease Cognitive Impairment Study (PaCoS).
    Donzuso G; Monastero R; Cicero CE; Luca A; Mostile G; Giuliano L; Baschi R; Caccamo M; Gagliardo C; Palmucci S; Zappia M; Nicoletti A
    Neurol Sci; 2021 Sep; 42(9):3723-3731. PubMed ID: 33447925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
    Gorges M; Kunz MS; Müller HP; Liepelt-Scarfone I; Storch A; Dodel R; Hilker-Roggendorf R; ; Berg D; Kalbe E; Braak H; Del Tredici K; Baudrexel S; Huppertz HJ; Kassubek J
    Hum Brain Mapp; 2020 Apr; 41(6):1416-1434. PubMed ID: 31789477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical relevance of amnestic versus non-amnestic mild cognitive impairment subtyping in Parkinson's disease.
    Chung SJ; Park YH; Yun HJ; Kwon H; Yoo HS; Sohn YH; Lee JM; Lee PH
    Eur J Neurol; 2019 May; 26(5):766-773. PubMed ID: 30565368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson's disease.
    Bakeberg MC; Gorecki AM; Kenna JE; Jefferson A; Byrnes M; Ghosh S; Horne MK; McGregor S; Stell R; Walters S; Chivers P; Winter SJ; Mastaglia FL; Anderton RS
    J Neurol; 2021 May; 268(5):1903-1912. PubMed ID: 33399968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain activity alterations in patients with Parkinson's disease with cognitive impairment based on resting-state functional MRI.
    Guo W; Jin W; Li N; Gao J; Wang J; Chang Y; Yin K; Chen Y; Zhang S; Wang T
    Neurosci Lett; 2021 Mar; 747():135672. PubMed ID: 33515623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant cerebral network topology and mild cognitive impairment in early Parkinson's disease.
    Pereira JB; Aarsland D; Ginestet CE; Lebedev AV; Wahlund LO; Simmons A; Volpe G; Westman E
    Hum Brain Mapp; 2015 Aug; 36(8):2980-95. PubMed ID: 25950288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments.
    Li L; Ji B; Zhao T; Cui X; Chen J; Wang Z
    PLoS One; 2022; 17(7):e0269787. PubMed ID: 35857782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's disease.
    Wolters AF; Moonen AJH; Lopes R; Leentjens AFG; Duits AA; Defebvre L; Delmaire C; Hofman PA; van Bussel FC; Dujardin K
    Cortex; 2020 Feb; 123():1-11. PubMed ID: 31733342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.